Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

EPI

Essa Pharma (EPI)

Essa Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:EPI
DatumZeitQuelleÜberschriftSymbolFirma
26/02/202100h33PR Newswire (Canada)ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of ShareholdersTSXV:EPIEssa Pharma Inc
13/01/202113h00PR Newswire (Canada)ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...TSXV:EPIEssa Pharma Inc
15/12/202023h01PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...TSXV:EPIEssa Pharma Inc
25/11/202013h00PR Newswire (Canada)ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx ConferenceTSXV:EPIEssa Pharma Inc
26/10/202022h01PR Newswire (Canada)ESSA Pharma Inc. Announces Delisting from the TSX-VTSXV:EPIEssa Pharma Inc
25/10/202001h18PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR SymposiumTSXV:EPIEssa Pharma Inc
19/10/202013h00PR Newswire (Canada)ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific SymposiaTSXV:EPIEssa Pharma Inc
21/09/202013h00PR Newswire (Canada)ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech SummitTSXV:EPIEssa Pharma Inc
17/09/202023h05PR Newswire (Canada)ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020TSXV:EPIEssa Pharma Inc
14/09/202013h00PR Newswire (Canada)ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...TSXV:EPIEssa Pharma Inc
10/09/202013h00PR Newswire (Canada)ESSA Pharma to Participate in Multiple Upcoming Investor ConferencesTSXV:EPIEssa Pharma Inc
07/08/202002h00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020TSXV:EPIEssa Pharma Inc
31/07/202016h16PR Newswire (Canada)ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000TSXV:EPIEssa Pharma Inc
29/07/202015h07PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - EPITSXV:EPIEssa Pharma Inc
29/07/202015h05PR Newswire (Canada)IIROC Trading Resumption - EPITSXV:EPIEssa Pharma Inc
29/07/202003h18PR Newswire (Canada)ESSA Pharma Announces Pricing of Public Offering of Common SharesTSXV:EPIEssa Pharma Inc
28/07/202022h03PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - EPITSXV:EPIEssa Pharma Inc
28/07/202022h01PR Newswire (Canada)ESSA Pharma Announces Proposed Public Offering of Common SharesTSXV:EPIEssa Pharma Inc
28/07/202022h01PR Newswire (Canada)IIROC Trading Halt - EPITSXV:EPIEssa Pharma Inc
15/07/202013h00PR Newswire (Canada)ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostra...TSXV:EPIEssa Pharma Inc
22/06/202013h30PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Me...TSXV:EPIEssa Pharma Inc
27/05/202013h00PR Newswire (Canada)ESSA Pharma to Present at Jefferies Virtual Healthcare ConferenceTSXV:EPIEssa Pharma Inc
15/05/202013h30PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual MeetingTSXV:EPIEssa Pharma Inc
07/05/202023h05PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020TSXV:EPIEssa Pharma Inc
30/04/202023h45PR Newswire (Canada)ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate CancerTSXV:EPIEssa Pharma Inc
14/04/202000h08PR Newswire (Canada)ESSA Pharma Enters into At-The-Market Equity Offering Sales AgreementTSXV:EPIEssa Pharma Inc
31/03/202013h00PR Newswire (Canada)ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business UpdateTSXV:EPIEssa Pharma Inc
28/02/202001h51PR Newswire (Canada)ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of ShareholdersTSXV:EPIEssa Pharma Inc
13/02/202023h48PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019TSXV:EPIEssa Pharma Inc
11/02/202000h15PR Newswire (Canada)ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific SymposiaTSXV:EPIEssa Pharma Inc
 Showing the most relevant articles for your search:TSXV:EPI